About atSpiro
atSpiro is a company based in Lyngby (Denmark) founded in 2019 by Frederik Petersen, Christian Emil Ege-Johansen, and Stanislav Ondrus. atSpiro has raised $172.88 thousand across 1 funding round. The company has 5 employees. atSpiro offers products and services including ShakeReactor. atSpiro operates in a competitive market with competitors including Limula, PBS Biotech, m2p-labs, Membio and Bionet Engineering, among others.
- Headquarter Lyngby, Denmark
- Employees 5
- Founders Frederik Petersen, Christian Emil Ege-Johansen, Stanislav Ondrus
- Stage Minicorn
- SectorsHealthcare
- Website atspiro.com
- Social LinkedIn Facebook
- Legal Name Atspiro Aps
- Net Profit-$52.13 K (USD)-21168as on Mar 31, 2021
- EBITDA-$78.31 K (USD)-24797as on Mar 31, 2021
- Total Equity Funding$172.88K (USD)
in 1 rounds
- Latest Funding Round$172.88K (USD), Seed
Dec 2020
- Employee Count5
Products & Services of atSpiro
atSpiro offers a comprehensive portfolio of products and services, including ShakeReactor.
Device for monitoring and controlling lab fermentations to optimize yields.
Funding Insights of atSpiro
atSpiro has successfully raised a total of $172.88K through 1 strategic funding round. The most recent funding activity was a Seed round of $172.88 thousand completed in December 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $172,879
- Total Rounds 1
- Last Round Seed — $172,879
- First Round $172,879
(Dec 2020)
All 1 funding rounds of atSpiro with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2020 | $172,879 | Seed | $1.4M | – | – |
| Date | Valuation | Stage |
|---|---|---|
| Dec 2020 | $1.4M | •••••••• |
Last known valuation $1.4M (Dec 2020).
People of atSpiro
4 people are tracked at atSpiro (4 in leadership); the tracked headcount is 5.
| Name | Role | Group |
|---|---|---|
Frederik Petersen | Co-Founder | Leadership |
Christian Emil Ege-Johansen | Co-Founder & CTO | Leadership |
Stanislav Ondrus | Co-Founder | Leadership |
Henning Lysdal | – | Leadership |
Complete people profiles for atSpiro
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of atSpiro
3 dated milestones of atSpiro across 1 years, from founding to its latest funding, stage changes and deals.
- Founded atSpiro is founded.
- Funding First funding round of $173K.
- Milestone Reaches Minicorn status.
Competitors of atSpiro
atSpiro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Limula, PBS Biotech, m2p-labs, Membio and Bionet Engineering, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| limula.ch | 2020 | – | – | – | Modular solutions for on-demand cell therapy manufacturing are provided. | |
| pbsbiotech.com | 2006 | Camarillo, United States | $70.21M | – | Developer of single-use bioreactors for the production of vaccines, therapeutic proteins, and cell therapies | |
| m2p-labs.com | 2005 | Baesweiler, Germany | – | 107 | Micro-bioreactors are provided for screening and bioprocess development. | |
| membio.ca | 2018 | Kitchener, Canada | $280,000 | – | Developer of single-use bioreactors for cell and gene therapies | |
| bionet.com | 1999 | Santiago Papasquiaro, Mexico | – | – | Manufactures bioreactors, TFF systems, and software for biopharma and agri-food applications. | |
| microbiopharm.com | 2011 | Tokyo, Japan | – | – | Contract research and discovery services are provided to biopharma firms. | |
| aucteq.com | 2018 | Mannheim, Germany | – | – | Single-use bioreactors for cell culturing processes are provided. | |
| hyalose.com | 2000 | Oklahoma, United States | – | – | Recombinant hyaluronic acid is manufactured in varying molecular sizes. |
Detailed competitors of atSpiro
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to atSpiro
10 companies that operate in the same segment as atSpiro (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about atSpiro
atSpiro was founded in 2019 and raised its 1st funding round 1 year after it was founded.
atSpiro is headquartered in Lyngby, Denmark. It is registered at Lyngby, Region Hovedstaden, Denmark.
atSpiro is a funded company, having raised a total of $172.88K across 1 funding round to date. The company's 1st funding round was a Seed of $172.88K, raised on Dec 2020.
atSpiro has 5 employees.
atSpiro was founded in 2019 in Lyngby, Denmark, within the biotechnology sector. Automated single-use bioreactors are produced for fermentation and cell cultivation of microbial cells. Patented sensor technology, known as ShakeReactor, is utilized as a wireless device for monitoring and control during shaking processes. Applications include strain selection, process optimization, cell expansion, pH control, and laboratory fed-batch production. A cloud-based database is integrated for computational analysis and data visualization.
atSpiro's top competitors include PBS Biotech, m2p-labs and Limula.
atSpiro offers ShakeReactor.
The valuation of atSpiro is $1.4M as of Dec 2020.
atSpiro operates through Atspiro Aps.